Basic info
Industry
biotechnology research
Sectors
Biotechnology
CACIPLIQ20®
Regenerative medicine
corneal lesions
RGTA®
CACICOL20®
healing
matrix therapy
ReGeneraTing Agents
ARDS
ischemic stroke
chronic wounds
Date founded
2000
Funding rounds raised
Total raised
$3.9M
from 1 investors over 1 rounds
O
OTR3 raised $3.9M on October 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)